Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Scheepers

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Neurology|March 20, 2003
Epilepsy and behaviourMark Scheepers, Mike Kerr
Brain Research|November 1, 2005
l-DOPA administration enhances 6-hydroxydopamine generationHimant Maharaj, Deepa Sukhdev Maharaj, Mark Scheepers, et al.
Expert Opinion on Pharmacotherapy|December 3, 2019
Quality improvement in the management of people with epilepsy and intellectual disability: the development of clinical guidanceLance Watkins, Máire O'Dwyer, Michael Kerr, et al.
Bjpsych Open|October 16, 2020
COVID-19 deaths in people with intellectual disability in the UK and Ireland: descriptive studyBhathika Perera, Richard Laugharne, William Henley, et al.
Journal of Neurology|April 6, 2023
Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case-control studyJames J Sun, Lance Watkins, William Henley, et al.
Journal of Neurology|January 24, 2022
Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national studyJames J Sun, Bhathika Perera, William Henley, et al.
Journal of Neurology|March 5, 2022
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national studyJames J Sun, Bhathika Perera, William Henley, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Neurology|March 20, 2003
Epilepsy and behaviourMark Scheepers, Mike Kerr
Brain Research|November 1, 2005
l-DOPA administration enhances 6-hydroxydopamine generationHimant Maharaj, Deepa Sukhdev Maharaj, Mark Scheepers, et al.
Expert Opinion on Pharmacotherapy|December 3, 2019
Quality improvement in the management of people with epilepsy and intellectual disability: the development of clinical guidanceLance Watkins, Máire O'Dwyer, Michael Kerr, et al.
Bjpsych Open|October 16, 2020
COVID-19 deaths in people with intellectual disability in the UK and Ireland: descriptive studyBhathika Perera, Richard Laugharne, William Henley, et al.
Journal of Neurology|April 6, 2023
Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case-control studyJames J Sun, Lance Watkins, William Henley, et al.
Journal of Neurology|January 24, 2022
Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national studyJames J Sun, Bhathika Perera, William Henley, et al.
Journal of Neurology|March 5, 2022
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national studyJames J Sun, Bhathika Perera, William Henley, et al.
Pageof 1